MF Gyan
sectorHigh risk14 years oldCooling recently (last 6m ≈ -1% p.a.)

UTI Value Fund - Direct Plan - Growth

Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings. From UTI Mutual Fund. It's been running since 2 Jan 2013.

Latest price per unit
₹181.9136
▼ 0.74% today
As of 2 Sep 2026 · updated once each business day

What ₹1 lakh would have become

Based on past returns
Invested 1 year ago
₹99.7k
▼ ₹291 loss · -0.3% / year
Invested 3 years ago
₹1.44 L
▲ ₹44.2k gain · 13.0% / year
Invested 5 years ago
₹1.72 L
▲ ₹71.9k gain · 11.4% / year

These are calculations from the fund's past prices, not a prediction. Real future returns can and often do differ.

SIP simulator

Play with a monthly investment

Slide the amount and switch the duration. Left column uses real past prices. Right column projects forward using this fund's historical rate — a calculation, not a prediction.

₹5.0k
Looking back · real
You would have invested₹1.80 L
Value today₹1.94 L
Gain / loss+₹13.8k
XIRR (annualised)5.12%
Looking forward · hypothetical
You would invest₹1.80 L
Would become*₹1.95 L
Projected gain*+₹14.9k
*at this fund's historical rate of 5.12% per year. Actual future returns can be different — sometimes very different.
Value Cumulative invested
Reality check. The backward SIP is real math on real past NAVs. The forward projection assumes the fund keeps up its historical rate — which rarely happens exactly. Past performance is not a promise. MF Gyan does not recommend any specific investment.
How it compares to peers

Vs 16 other funds in Equity Schemes - Value Fund

Same plan
1-year return
-0.29%median 3.77% (-4.06%)
Rank #14 of 17Beats 7% of peers
3-year return
12.98%median 13.87% (-0.89%)
Rank #10 of 17Beats 25% of peers
5-year return
11.44%median 11.95% (-0.51%)
Rank #9 of 17Beats 0% of peers
Bumpiness (3Y)
13.40%median 14.08% (-0.68%)
Rank #2 of 17Less risky than 93% of peers
Worst-ever drop
-36.68%median -24.02% (-12.65%)
Rank #9 of 17Less risky than 50% of peers

Descriptive rankings within the same category and plan. Not a recommendation — one fund beating another historically does not mean it will continue to do so.

Year by year

Calendar-year returns. 6 of last 7 years were positive.

+20%
2020
+31%
2021
+4%
2022
+27%
2023
+24%
2024
+8%
2025
-5%
2026
Best year
2021 · 30.74%
Worst year
2026 · -5.49%

Price over time

How the per-unit price has moved. Tap a range to zoom in.

Bumpiness & worst drops

Day-to-day bumpiness
13.4%

The value swings roughly 13% up or down in a typical year. Finance-speak calls this volatility.

Worst drop ever
-36.68%

A lump sum invested at the previous peak would have temporarily lost about this much before recovering. Finance-speak calls this max drawdown.

Similar funds you might want to look at

Same category, same plan, sorted by 3-year return. Not recommendations — just neighbours.

Head-to-head comparisons

Side-by-side comparisons of UTI Value Fund - Direct Plan - Growth against other sector funds.

Technical details (for the pros)
CAGR — 1 year-0.29%
CAGR — 3 years12.98%
CAGR — 5 years11.44%
CAGR — since launch13.43%
Volatility — 1 year (annualised)13.14%
Volatility — 3 years (annualised)13.40%
Max drawdown — 1 year-15.28%
Max drawdown — 3 years-17.23%
Sharpe ratio — 1 year (rf=6%)-0.48
Sharpe ratio — 3 years (rf=6%)0.47

Fund info

Fund house
UTI Mutual Fund
Category
Equity Schemes - Value Fund
Plan
Direct
Option
Growth
ISIN (Growth)
INF789F01VB2
ISIN (Div re-invest)
—
Fund code
120751
First price on record
2 Jan 2013 · 3,363 daily prices

About UTI Value Fund - Direct Plan - Growth

UTI Value Fund - Direct Plan - Growth is a Equity Schemes - Value Fund offered by UTI Mutual Fund under the Direct plan with the Growth option. It has approximately 14 years of NAV track record. The fund falls in the sector category — Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings.

The current NAV of UTI Value Fund - Direct Plan - Growth is ₹181.9136 (as of 2 Sep 2026). Historically, it has delivered -0.29% over the last year, 12.98% CAGR over 3 years, 11.44% CAGR over 5 years. Returns are historical and don't predict future performance.

Over the last three years, the fund's prices have moved with 13.4% annualised volatility — a "high" level of bumpiness; its deepest peak-to-trough fall on record was 36.7%. Being mentally prepared for drawdowns of this size is what separates long-term investors from reactive traders.

Frequently asked

What is the latest NAV of UTI Value Fund - Direct Plan - Growth?+

The latest NAV of UTI Value Fund - Direct Plan - Growth is ₹181.9136 as of 2 Sep 2026, down 0.74% from the previous day. NAV is updated once a business day after the market close.

What are the returns of UTI Value Fund - Direct Plan - Growth?+

UTI Value Fund - Direct Plan - Growth has delivered 1-year return -0.29%, 3-year CAGR 12.98%, 5-year CAGR 11.44%, since-inception CAGR 13.43%. Returns are historical and don't predict future performance — markets move in cycles.

What category does UTI Value Fund - Direct Plan - Growth belong to?+

UTI Value Fund - Direct Plan - Growth is categorised as Equity Schemes - Value Fund. Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings.

How risky is UTI Value Fund - Direct Plan - Growth?+

Based on its 3-year annualised volatility of 13.4%, UTI Value Fund - Direct Plan - Growth sits in the "high" risk bucket. Volatility measures how much prices swing — higher means bigger ups and downs along the way.

Is UTI Value Fund - Direct Plan - Growth a direct plan?+

UTI Value Fund - Direct Plan - Growth is a Direct plan (no distributor commission — lower expense ratio) with the Growth option (all returns compound within the fund, no interim payouts).

How old is UTI Value Fund - Direct Plan - Growth?+

UTI Value Fund - Direct Plan - Growth has NAV history available from 2 Jan 2013 — approximately 14 years of track record and 3,363 daily NAV observations.

Numbers are computed from stored daily prices from mfapi.in/AMFI. This is descriptive analytics, not investment advice. Past performance is not indicative of future returns.